Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCA vs TPCA in Metastatic Esophageal and Gastric Cancer
NCT00911820Phase 2Completed
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Jul 2009
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in esophageal cancer, gastric cancer (GC), sponsored by Dana-Farber Cancer Institute. Started Jul 2009; status: completed.
02
Drugs
docetaxel
03
Conditions
esophageal cancergastric cancer (GC)
Beyond the preview
Go deeper on NCT00911820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00911820.